PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'COVID-19 Response Team, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.\', \'Laboratory Leadership Service, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.\', \'Arizona Department of Health Services, Phoenix, Arizona, USA.\', \'Epidemic Intelligence Service, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.\', \'Pima County Health Departmentgrid.437380.b, Tucson, Arizona, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1128/JCM.01742-21
?:hasPublicationType
?:journal
  • Journal of clinical microbiology
is ?:pmid of
?:pmid
?:pmid
  • 34705535
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.256
?:rankingScore_hIndex
  • 226
?:title
  • Performance Characteristics of the Abbott BinaxNOW SARS-CoV-2 Antigen Test in Comparison to Real-Time Reverse Transcriptase PCR and Viral Culture in Community Testing Sites during November 2020.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all